Breast Cancer

Navigating Oral Therapy in Breast Cancer: Practice Strategies to Promote Medication Adherence

The Academy of Oncology Nurse & Patient Navigators (AONN+) and Eli Lilly and Company Medical Affairs are pleased to present a live webinar designed to facilitate conversations with patients regarding adherence to breast cancer treatments. Attendees will have an opportunity to participate in a live Q&A following the presentation.

Cerianna PET-CT: Identifying Patients Who May Benefit

A recent AONN+ annual conference session discussed an FDA-approved PET imaging agent, which is used as an adjunct to biopsy for the detection of estrogen receptor (ER)-positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer.

A Survivor and a Navigator

2019 ONE Award winner Susie Ulloa discusses how her experience as a breast cancer survivor has influenced how she navigates her patients.